Article Text
Statistics from Altmetric.com
Footnotes
Contributors KRS wrote the first draft which was critically edited and reviewed by PFC.
Funding PFC is a Wellcome Trust Principal Research Fellow (212219/Z/18/Z), and a UK NIHR Senior Investigator, who receives support from the Medical Research Council Mitochondrial Biology Unit (MC_UU_00028/7), the Medical Research Council (MRC) International Centre for Genomic Medicine in Neuromuscular Disease (MR/S005021/1) which also supports KRS, the Leverhulme Trust (RPG-2018-408), an MRC research grant (MR/S035699/1), an Alzheimer's Society Project Grant (AS-PG-18b-022). This research was supported by the NIHR Cambridge Biomedical Research Centre (BRC-1215-20014).
Disclaimer The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care.
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed by Rhys Thomas, Newcastle-upon-Tyne, UK.
Read the full text or download the PDF:
Other content recommended for you
- Use of whole genome sequencing to determine genetic basis of suspected mitochondrial disorders: cohort study
- Mitochondrial molecular genetic results in a South African cohort: divergent mitochondrial and nuclear DNA findings
- Clinical mitochondrial genetics
- Diagnosis and therapy in neuromuscular disorders: diagnosis and new treatments in mitochondrial diseases
- Diagnosis of ‘possible’ mitochondrial disease: an existential crisis
- Mitochondrial disease: mimics and chameleons
- Recognition, investigation and management of mitochondrial disease
- Could it be mitochondrial? When and how to investigate
- SANDO syndrome in a cohort of 107 patients with CPEO and mitochondrial DNA deletions
- Mitochondrial disease and the heart